A Phase I Trial of Tamoxifen and 9-Cis-Retinoic Acid in Breast Cancer Patients

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

May 31, 1996

Study Completion Date

January 31, 2002

Conditions

Breast CancerBreast Neoplasm

Interventions

DRUG

9-cis-Retinoic Acid

Trial Locations (1)

National Cancer Institute (NCI), Bethesda

All Listed Sponsors

lead

National Cancer Institute (NCI)

NIH

NCT00001504 - A Phase I Trial of Tamoxifen and 9-Cis-Retinoic Acid in Breast Cancer Patients | Biotech Hunter | Biotech Hunter